Pancreastatin, a presumed product of chromogranin A (secretory protein-I) processing, may be an autocrine inhibitor of parathyroid secretion

B. H. Fasciotto, S. U. Gorr, D. J. DeFranco, G. H. Greeley, M. A. Levine, D. V. Cohn

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Original languageEnglish (US)
Title of host publicationCalcium regulation and bone metabolism. Basic and clinical aspects
Subtitle of host publicationproceedings of the 10th International Conference on calcium regulating hormones and bone metabolism. ICS886
EditorsD.V. Cohn, F.H. Glorieux, T.J. Martin, D.V. Cohn, F.H. Glorieux, T.J. Martin
PublisherElsevier Science Publishers B.V.
Pages51-56
Number of pages6
ISBN (Print)0444813292
StatePublished - Jan 1 1990
EventThe 10th International Conference on calcium regulating hormones and bone metabolism -
Duration: Sep 9 1989Sep 14 1989

Other

OtherThe 10th International Conference on calcium regulating hormones and bone metabolism
Period9/9/899/14/89

Cite this

Fasciotto, B. H., Gorr, S. U., DeFranco, D. J., Greeley, G. H., Levine, M. A., & Cohn, D. V. (1990). Pancreastatin, a presumed product of chromogranin A (secretory protein-I) processing, may be an autocrine inhibitor of parathyroid secretion. In D. V. Cohn, F. H. Glorieux, T. J. Martin, D. V. Cohn, F. H. Glorieux, & T. J. Martin (Eds.), Calcium regulation and bone metabolism. Basic and clinical aspects: proceedings of the 10th International Conference on calcium regulating hormones and bone metabolism. ICS886 (pp. 51-56). Elsevier Science Publishers B.V..